# CIO Review: Enterprise Pilot Readiness (Pass 1)

**Date:** 2026-02-13  
**Scope:** Operations, governance, and health-system onboarding readiness  
**Context:** Ramsey Health Australia pilot, Meditech-to-OpenEHR migration

## Executive Verdict
**Controlled go** for a narrow internal pilot, with CIO-level governance gates enforced before external rollout.

## Enterprise Readiness Assessment
The codebase is architecturally complete for pilot trials, but enterprise governance and onboarding readiness are not yet mature enough for broad deployment.

Main gap: the system can run advanced clinical functions, but pilot governance (tenant controls, migration runbooks, and operational accountability) is only partially formalized.

## Key Findings

### CIO-1 — No Enterprise-Grade OpenEHR Readiness Contract
Severity: P1  
Likelihood: High  
Evidence: `backend/app/connectors/`, `docs/agent_context_health_graph.md`, `tasks/03_wiring_audit.md`  
Impact: Data onboarding from Meditech is exposed to schema drift and interpretation risk during migration.  
Owner: VP Product + Architecture + Clinical Informatics  
Pilot Recommendation: **Hold** broad rollout until OpenEHR canonical contract is approved by enterprise informatics.

### CIO-2 — Missing Single Operational Runbook for Ingestion→Ontology→KG→QA
Severity: P2  
Likelihood: High  
Evidence: `tasks/03_wiring_audit.md`, `tasks/04_enterprise_readiness_multi_agent_playbook.md`, `backend/app/api/nlp.py`  
Impact: Different teams cannot predictably reproduce outputs across environments.  
Owner: Platform + Product + Clinical AI  
Pilot Recommendation: **Controlled go** with one documented playbook and one canonical UI path.

### CIO-3 — Security Controls Not Yet Enforced at Enterprise Policy Layer
Severity: P1  
Likelihood: High  
Evidence: `backend/app/core/config.py` (auth default), `backend/app/services/graph_database_service.py` (mock mode), `AGENT_PROMPT_TEMPLATE` context  
Impact: Clinical governance and risk acceptance are currently operationally unbounded for external use.  
Owner: Security + Engineering  
Pilot Recommendation: **Hold** until controls are policy-locked and monitored.

### CIO-4 — Audit and Escalation Ownership Paths Are Not Fully Defined for Clinical-Production Incidents
Severity: P2  
Likelihood: Medium  
Evidence: `backend/app/middleware/audit_middleware.py`, `backend/app/api/clinical_agent.py`, `backend/app/core/queue.py`  
Impact: Incident response latency can grow due to unclear ownership and handoff boundaries.  
Owner: Operations + Product + Clinical Leadership  
Pilot Recommendation: **Controlled go** with written on-call and escalation matrix.

### CIO-5 — No Explicit Data Governance Layer for Australian Residency / Consent
Severity: P2  
Likelihood: Medium  
Evidence: `backend/app/models/clinical_fact.py`, `backend/app/services/clinical_data_review_service.py`, `backend/app/services/fhir_import.py`  
Impact: Regional governance obligations can be violated without source flags and retention policy enforcement.  
Owner: Compliance + Product + Legal  
Pilot Recommendation: **Hold** for external rollout until retention and consent metadata are enforceable.

### CIO-6 — Health System Onboarding Complexity Not Reduced to a Scripted Checklist
Severity: P1  
Likelihood: High  
Evidence: `backend/app/connectors/fhir_connector.py`, `backend/app/api/fhir.py`, `exec-review/interop-review.md`  
Impact: Integration onboarding can become ad hoc and fail unpredictably.  
Owner: Interop + CTO + CPO  
Pilot Recommendation: **Controlled go** with pilot onboarding checklist and staged acceptance.

### CIO-7 — Data Quality SLAs Are Not Formalized for Clinical Risk Domains
Severity: P2  
Likelihood: High  
Evidence: `tasks/02_agent_findings.md`, `backend/app/services/clinical_ontology_mapper.py`, `backend/app/services/clinical_outcome_assessment_service.py`  
Impact: Ingestion and normalization accuracy not bound to clinical risk classes.  
Owner: Clinical AI + VP Product  
Pilot Recommendation: **Controlled go** with per-workflow SLOs.

### CIO-8 — Multi-Tenant Isolation Framework Is Not Pilot-Operational
Severity: P2  
Likelihood: Medium  
Evidence: `backend/app/security/rbac_service.py`, `backend/app/core/tenant.py`  
Impact: Scaling to multiple departments/sites in one environment will require policy rework.  
Owner: Engineering + Security  
Pilot Recommendation: **Hold** only if expansion beyond single pilot tenant is planned.

### CIO-9 — No Explicit "What to do when Accuracy is 77%" Operating Policy
Severity: P2  
Likelihood: High  
Evidence: `backend/app/services/hybrid_clinical_analyzer.py`, `exec-review/clinical-ai-review.md`  
Impact: Clinical teams cannot infer when model-derived answers require manual escalation.  
Owner: VP Product + Clinical AI  
Pilot Recommendation: **Controlled go** with confidence gates in workflow UI.

### CIO-10 — Production Support Contract Not Yet Costed for Pilot Scale
Severity: P2  
Likelihood: Medium  
Evidence: `backend/app/services/clinical_agent.py`, `backend/app/core/queue.py`, `docker-compose.yml`  
Impact: Staffing and on-call model not yet defined for sustained use.  
Owner: Ops + CIO Office + Finance  
Pilot Recommendation: **Controlled go** with support and capacity guardrails.

## Pilot Governance Checklist
- Single source tenant for pilot (single department/site).
- Confirmed OpenEHR transformation contract and source-of-truth mappings from Meditech.
- Enforced clinical escalation protocol for `low_confidence` / `degraded` outputs.
- Readiness criteria signed by:
  - CIO office
  - Clinical lead
  - Security lead
  - Platform lead
- Escalation contacts and response timeline preloaded before launch.

## CIO Go/No-Go
Proceed only if:
- OpenEHR onboarding workflow is deterministic and auditable.
- Incident response and escalation are in place with named owners.
- Consent/residency and retention policy controls are operational for Australia.
- Confidence and escalation behaviors are explicit to end users and clinical leads.
